Reiss M - Search Results

1

Transforming growth factor-beta in breast cancer: a working hypothesis.

Reiss M, Barcellos-Hoff MH. Reiss M, et al. Breast Cancer Res Treat. 1997 Aug;45(1):81-95. doi: 10.1023/a:1005865812918. Breast Cancer Res Treat. 1997. PMID: 9285120 Review.

2

Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.

Souza RF, Garrigue-Antar L, Lei J, Yin J, Appel R, Vellucci VF, Zou TT, Zhou X, Wang S, Rhyu MG, Cymes K, Chan O, Park WS, Krasna MJ, Greenwald BD, Cottrell J, Abraham JM, Simms L, Leggett B, Young J, Harpaz N, Reiss M, Meltzer SJ. Souza RF, et al. Among authors: reiss m. Hum Cell. 1996 Sep;9(3):229-36. Hum Cell. 1996. PMID: 9183654

3

Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene.

Vellucci VF, Reiss M. Vellucci VF, et al. Among authors: reiss m. Genomics. 1997 Dec 1;46(2):278-83. doi: 10.1006/geno.1997.5023. Genomics. 1997. PMID: 9417915

4

Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.

Guinness ME, Kenney JL, Reiss M, Lacy J. Guinness ME, et al. Among authors: reiss m. Cancer Res. 2000 Oct 1;60(19):5354-8. Cancer Res. 2000. PMID: 11034070

5

Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma.

Chen T, de Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A, Reiss M. Chen T, et al. Among authors: reiss m. Int J Cancer. 1999 Jul 2;82(1):43-51. doi: 10.1002/(sici)1097-0215(19990702)82:1<43::aid-ijc9>3.0.co;2-0. Int J Cancer. 1999. PMID: 10360819

6

Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4.

Reiss M, Santoro V, de Jonge RR, Vellucci VF. Reiss M, et al. Cell Growth Differ. 1997 Apr;8(4):407-15. Cell Growth Differ. 1997. PMID: 9101086

7

A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression.

Muñoz-Antonia T, Li X, Reiss M, Jackson R, Antonia S. Muñoz-Antonia T, et al. Among authors: reiss m. Cancer Res. 1996 Nov 1;56(21):4831-5. Cancer Res. 1996. PMID: 8895728

8

Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.

de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M. de Jonge RR, et al. Among authors: reiss m. Oncol Res. 1997;9(2):89-98. Oncol Res. 1997. PMID: 9167190

9

Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.

Chen T, Yan W, Wells RG, Rimm DL, McNiff J, Leffell D, Reiss M. Chen T, et al. Among authors: reiss m. Int J Cancer. 2001 Sep 1;93(5):653-61. doi: 10.1002/ijc.1381. Int J Cancer. 2001. PMID: 11477574

10

Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting.

Burtness B, Windsor S, Holston B, DiStasio S, Staugaard-Hahn C, Abrantes J, Kneuper-Hall R, Farber L, Orell J, Bober-Sorcinelli K, Haffty BG, Reiss M. Burtness B, et al. Among authors: reiss m. Cancer J Sci Am. 1999 Jul-Aug;5(4):224-9. Cancer J Sci Am. 1999. PMID: 10439168 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results